SAN DIEGO, April 11, 2012 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced the release of its new patient compliance management solution, EasyCare Online. The innovative new tool aggregates ...
With SleepSeeker, patients using ResMed's S9™ series air flow generators will be able to view their own therapy data just as a doctor might see it, including time used, and any apnea or hypopnea ...
Medical equipment maker ResMed will pay $37.5 million to resolve allegations brought by the Department of Justice (DOJ) that it paid kickbacks to durable medical equipment suppliers, sleep labs and ...
ResMed is a dominant player in healthcare devices with strong margins, recurring revenues, and a near-monopoly, offering a compelling mix of value and growth. The company continually invests in R&D, ...
ResMed CEO Mick Farrell, speaking to The Weekend Australian from the US after reporting a 13 per cent lift in quarterly revenue, said the biotech had more than three billion nights’ worth of sleep ...
ResMed reported $1.28 billion in revenue and $2.43 EPS, driven by strong demand for AirSense 11 and effective cost management. Rising awareness of sleep apnea, aided by wearable devices like Apple ...
ResMed's fifth annual Global Sleep Survey highlights a significant global sleep crisis, revealing that 71% of employed individuals have called in sick at least once due to poor sleep, with the average ...
Resmed announced that it will release its financial and operational results for the fourth quarter of fiscal year 2025 on July 31, 2025, after the market closes. Following the release, management will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback